-+ 0.00%
-+ 0.00%
-+ 0.00%

ADITXT SUBSIDIARY PEARSANTA RECEIVES IRB APPROVAL TO INITIATE CLINICAL STUDY OF BLOOD-BASED DIAGNOSTIC FOR ENDOMETRIOSIS WITH PATIENT ENROLLMENT PLANNED TO BEGIN IN MAY 2025

Reuters·04/16/2025 12:15:00

Please log in to view news